Psychological Intervention for Persons in the Early Initial Prodromal State

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 1999 by University of Cologne.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
German Federal Ministry of Education and Research
German Research Network On Schizophrenia
Department of Psychiatry University of Bonn
Heinrich-Heine University, Duesseldorf
Ludwig-Maximilians - University of Munich
Information provided by:
University of Cologne
ClinicalTrials.gov Identifier:
NCT00204087
First received: September 12, 2005
Last updated: January 10, 2006
Last verified: June 1999

September 12, 2005
January 10, 2006
January 2001
Not Provided
transition to subthreshold psychosis (and psychosis or schizophrenia)
  • social adjustment
  • improvement of prodromal symptoms (basic symptoms, depression, social anxiety)
Complete list of historical versions of study NCT00204087 on ClinicalTrials.gov Archive Site
  • improvement of prodromal symptoms (basic symptoms, depression, anxiety)
  • social adjustment
progression to psychosis
Not Provided
Not Provided
 
Psychological Intervention for Persons in the Early Initial Prodromal State
Psychological Intervention for Persons at Risk of Psychosis in the Early Initial Prodromal State

The purpose of this randomized controlled trial is to develop a cognitive behavioral therapy (CBT) for persons with at risk mental states in the early initial prodromal state and to evaluate CBT in comparison to supportive counselling (SC).It is hypothesized that CBT is more effective than SC on transition to subthreshold psychosis, psychosis and schizophrenia as well as on prodromal symptoms and social adjustment.

Several studies indicated that self-perceived cognitive thought and perception deficits (basic symptoms), negative symptoms, anxiety, depressive symptoms and social stagnation or social decline are usually present years before the first episode of schizophrenia appears. It is also known that delayed treatment of schizophrenia correlates with a poor prognosis, low compliance and high family burden. As consequence of these findings, for the first time we developed a cognitive behavioral therapy (CBT) for persons at risk for psychosis in the early initial prodromal state. The early initial prodromal state was defined by the presence of self-perseived neuropsychological deficits, which were found to be predictive for transition to psychosis and by the presence of clinical relevant decline of functioning in combination with that of clinical management (CM). Is CBT more effective than CM with regard to the three aims of intervention 1. transition to psychosis, 2. improvement of prodromal symptoms, 3. prevention of social decline/stagnation, ? A randomized controlled trail is used to compare the efficacy of CBT with that of supportive counselling (SC). Patients are randomized to receive either CBT or SC over a 12 months period. CBT comprises of individual and group therapy as well as cognitive remediation and psychoeducation for key persons. SC should provide regular supportive contacts for the patient. No CBT strategies are allowed to be systematically applied in SC.

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Schizophrenia
  • Psychosis
  • Behavioral: Cognitive behavioral therapy (CBT)
  • Behavioral: Supportive Counselling (SC)
Not Provided
Bechdolf A, Wagner M, Ruhrmann S, Harrigan S, Putzfeld V, Pukrop R, Brockhaus-Dumke A, Berning J, Janssen B, Decker P, Bottlender R, Maurer K, Möller HJ, Gaebel W, Häfner H, Maier W, Klosterkötter J. Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry. 2012 Jan;200(1):22-9. doi: 10.1192/bjp.bp.109.066357. Epub 2011 Nov 10.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
126
June 2005
Not Provided

Inclusion Criteria:

  1. General criteria

    • Age between 17 and 36 years
    • male or female, in- or outpatients
    • written informed consent, for patients below 18 years also signed by their parents
  2. Special criteria (presented within the last three months prior to the study)

    1. Self-experienced neuropsychological deficits (basic symptoms)

      • Thought interferences
      • Compulsory like perseverance of thoughts
      • Thought pressure
      • Thought blockages
      • Disturbances of receptive language, either heard or read
      • Decreased ability to discriminate between ideas and perception, fantasy and true memories
      • Unstable ideas of reference (subject-centrism)
      • Derealisation
      • Visual perceptual disturbances (blurred vision, transitory blindness, partial seeing, hypersensitivity of light, etc..)
      • Acoustic perceptual disturbances (hypersensitivity to sounds or noise (hypersensitivity to sounds or noise, acoasms, etc.) AND/OR
    2. Reduction in the Global Assessment of Functioning Score (DSM IV) of at least 30 points (within the past year) and at least one of the following risk factors:

      • First-degree relative with a lifetime-diagnosis of schizophrenia or
      • a schizophrenia spectrum disorder
      • Pre-or perinatal complications

Exclusion Criteria:

  • Attenuated or transient positive symptomes
  • Present or past diagnosis of a schizophrenic, schizophreniform, schizoaffective, delusional or bipolar according to DSM IV
  • Present or past diagnosis a brief psychotic disorder according to DSM IV with a duration of more than one week or within the last 4 weeks regardless of its duration
  • Diagnosis of delirium, dementia, amnestic or other cognitive disorder, mental retardation psychiatric disorder due to a somatic factor or related to the consumption of psychotropic substances according DSM IV
  • Alcohol- or drug abuse within the last three months prior to inclusion according to DSM IV
  • Deases of the central nervous system (inflammatory, traumatic, epilepsy etc.)
Both
17 Years to 36 Years
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00204087
01 GI 9935 – P 1.1.2
Not Provided
Not Provided
University of Cologne
  • German Federal Ministry of Education and Research
  • German Research Network On Schizophrenia
  • Department of Psychiatry University of Bonn
  • Heinrich-Heine University, Duesseldorf
  • Ludwig-Maximilians - University of Munich
Study Chair: Andreas Bechdolf, Dr. Department of Psychiatry and Psychotherapy, University of Cologne
University of Cologne
June 1999

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP